ScholarIQanswers from OpenAlex

Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease

PaperCitations, authors & open-access status

Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease have?

ScholarIQcitation count

Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease has 269 citations in the OpenAlex counts ScholarIQ stores.

When was Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease published?

ScholarIQyear

Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease has 2011 year in the ScholarIQ index.

What is the open-access status of Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease?

ScholarIQoa status

Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease has bronze oa status in the ScholarIQ index.

What is the DOI of Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease?

ScholarIQdoi

The DOI for Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease is on the source record.

What is the PMID of Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease?

ScholarIQpmid

The PMID for Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease is on the source record.

What is the OpenAlex record for Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease?

ScholarIQopenalex

The OpenAlex for Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial